Niraparib Tosylate Monohydrate ( —— )

产品货号. M21829 CAS No. 1613220-15-7

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

拼团产品询价大包装询价加入购物车

产品名称

Niraparib Tosylate Monohydrate
注意事项

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
产品简述

Niraparib is an orally active small molecule PARP inhibitor developed by Tesaro to treat ovarian cancer.
产品描述

Niraparib is an orally active small molecule PARP inhibitor developed by Tesaro to treat ovarian cancer.It is used for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete or partial response to platinum-based chemotherapy.Niraparib is an orally active small molecule PARP inhibitor developed by Tesaro to treat ovarian cancer.
同义词

——
通路

Others
靶点

Other Targets
受体

——
研究领域

——
适应症

——

CAS Number

1613220-15-7
分子量

510.61
分子式

C26H30N4O5S
纯度

>98% (HPLC)
溶解度

——
SMILES

O.CC1=CC=C(C=C1)S(O)(=O)=O.[H][C@]1(CCCNC1)C1=CC=C(C=C1)N1C=C2C=CC=C(C(O)=N)C2=N1
化学全称

2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboximidic acid 4-methylbenzene-1-sulfonic acid hydrate

计算器

产品手册

关联产品

Glucagon-like peptid...

Glucagon-like peptide 1 (1-37), human (TFA) is a highly potent agonist of the GLP-1 receptor, it is a kind of pancreatic hormone synthesized by post-translational processing of proglucagon.
Methyl nomilinate

Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.
Methyl nomilinate

Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.